Universal Health Services
UHS · What the business does, what can go wrong, and how options sellers approach it
What it does
Universal Health Services owns and operates hospitals and other care facilities in the United States, and it also has operations in the United Kingdom. It runs in two main segments: acute care hospitals and behavioral health (mental health and addiction treatment) facilities. It also operates surgical hospitals, ambulatory surgery centers and radiation oncology centers.
How it makes money
The company earns fees for patient care. Payers include government programs such as Medicare and Medicaid, commercial health insurers and, to a smaller degree, patients themselves. Revenue depends on how many patients are admitted or treated, how long they stay, the mix of services provided, and the rates each payer agrees to pay. Labor is the largest cost, so staffing levels and wages strongly affect profit.
Why investors own it
Demand for hospital care and behavioral health treatment tends to be steady across economic cycles. Investors may like the company's mix of general hospitals and behavioral health, a field with ongoing demand. The company has also historically returned capital through share repurchases. Class B shares are the listed common stock most investors trade.
What can go wrong
- Government reimbursement changes can cut payment rates.
- Labor shortages and wage inflation can squeeze margins.
- Insurers may push back on rates or deny claims.
- Behavioral health facilities face legal, regulatory and reputational risk, including lawsuits over patient care.
- Changes in insurance coverage, such as Medicaid eligibility shifts, can alter patient volumes and payer mix.
What to watch
- Admissions and patient days
- Revenue per admission or per patient day
- Payer mix, especially Medicaid and commercial share
- Salaries, wages and benefits as a share of revenue
- Contract labor usage
- Federal and state reimbursement rule updates
- Legal and regulatory developments in behavioral health
- Capital spending and share repurchase activity
Options income angle
Options on UHS are generally available, but they are usually less liquid than those on the largest healthcare names. Bid-ask spreads can be wider, especially on strikes far from the current price and longer-dated contracts. Implied volatility tends to rise ahead of quarterly earnings and around policy news, such as reimbursement rule changes or healthcare legislation. One caution for premium sellers: a sharp move after earnings or a regulatory headline can quickly turn a short call or put into a loss, and thin liquidity can make adjusting the position costly.
What the latest 10-K says
A plain-English read of the Risk Factors and Management's Discussion in the 10-K for the year ended December 31, 2025, filed February 25, 2026. Figures are as the filing reports them. Read the filing on SEC.gov
The filing in brief
Universal Health Services grew revenue and profit in 2025 across both its hospital and behavioral health businesses. The filing's weight falls on future pressure: federal Medicaid changes that start cutting supplemental payments from 2028, two large jury verdicts against subsidiaries, and a $700 million bond that must be refinanced at higher rates in 2026.
How the business did
- Net revenues increased by 9.7%, or $1.54 billion, to $17.36 billion during 2025, versus $15.83 billion in 2024. Facilities owned in both years contributed a $1.25 billion or 8.2% increase, and two new hospitals added to the rest.
- Net income attributable to UHS rose 30% to $1.49 billion from $1.14 billion. The gain included a $93 million unrealized gain on a minority stake in a healthcare generative artificial intelligence company.
- Acute care income before income taxes increased by $207 million, or 25%, to $1.05 billion, despite a $49 million pre-tax loss at the newly opened Cedar Hill Regional Medical Center and an $18 million legal reserve for the Pinnacle verdict. Behavioral health rose $105 million, or 7.7%, to $1.46 billion.
- Net cash from operations was $1.864 billion, versus $2.067 billion in 2024. Receivables grew, and days sales outstanding (how many days of revenue sit uncollected) were 55 days versus 50 days. The company spent $1.015 billion on capital expenditures and $899 million on open-market share repurchases.
- Interest expense fell to $156 million from $186 million.
Risks specific to this company
- Medicaid funding cuts: The July 4, 2025 federal law adds Medicaid work requirements and limits provider fees states use to fund supplemental payments. The company estimates its aggregate annual net benefit will be reduced by approximately $432 million to $480 million by 2032, starting with the 2028 state fiscal years.
- Cumberland litigation: A jury awarded three plaintiffs $60 million in compensatory damages, $180 million in trebled damages and $120 million in punitive damages against a Virginia subsidiary. The court cut the punitive amount to a combined maximum of $1.05 million, and the verdict is on appeal. About 40 more plaintiffs are pending, with the next trial tentatively planned for August 2026. Remaining 2020-year insurance coverage is approximately $143 million.
- Pinnacle verdict in Nevada: A jury awarded approximately $4.7 million in compensatory damages and $500 million in punitive damages against a UHS subsidiary. The company expects the punitive amount to be reduced to a maximum of approximately $14 million and plans to challenge the verdict.
- Geographic concentration: Texas contributed 16% of net revenues in 2025, Nevada 17% and California 11%. Medicaid, wildfire and staffing-rule changes in those states hit disproportionately.
- Refinancing: The $700 million, 1.65% senior notes mature on September 1, 2026. The company expects to refinance them at significantly higher interest rates, which will reduce net income.
- Voting control: Class A and C shares hold 90.8% of general voting power, and the Miller family controls most of them. The filing flags potential conflicts of interest.
What management is watching
- Capital spending of approximately $950 million to $1.1 billion in 2026, for equipment, new facilities and expansions.
- Whether the enhanced insurance exchange subsidies that expired on December 31, 2025 are extended. A House-passed bill is under Senate review, and management says it cannot predict the outcome.
- Medicare rate updates, which management estimates at approximately 2.7% for inpatient acute care and 1.7% for inpatient psychiatric payments in federal fiscal year 2026.
- The planned restructuring of the George Washington University physician arrangement for the District hospitals, expected to close in the second quarter of 2026.
- Same Facility results (a non-GAAP measure covering only facilities operated in both years), which management uses to gauge operating performance.
What the latest 10-Q says
A plain-English read of Management's Discussion (and any new or changed risk factors) in the 10-Q for the quarter ended September 30, 2026, filed November 6, 2026. Figures are as the filing reports them. Read the filing on SEC.gov
The quarter in brief
UHS grew net revenues by 5.3%, or $238 million, to $4.733 billion in the third quarter, but net income attributable to UHS fell by $64 million, or 17%, to $309 million. Costs rose faster than revenue, interest expense climbed, and a higher reserve for liability claims weighed on results. The company also completed its acquisition of Talkspace and refinanced maturing debt with new, higher-rate notes.
How the business did
- Quarter: Same Facility revenue (facilities operated in both periods) rose 4.4%. Income before income taxes decreased by $83 million, or 17%, to $414 million. The company said Medicaid supplemental payments for prior periods cut revenue growth by $37 million.
- Nine months: Net revenues increased by 7.7%, or $988 million, to $13.867 billion. Net income attributable to UHS decreased by $27 million, or 3%, to $1.016 billion.
- Segments: Acute care income before income taxes on a Same Facility basis fell 5.3% to $302 million. Behavioral health income before income taxes fell 8.4% to $316 million, mostly from an unfavorable swing at Laurel Ridge Treatment Center. The company raised reserves for self-insured professional and general liability claims by $37 million in the quarter and $65 million for the nine months, citing unfavorable trends and a tentative legal settlement.
- Cash and capital: Operating cash flow for the nine months was $1.481 billion, compared with $1.290 billion a year earlier. The company spent $690 million on open market share repurchases, $660 million on capital expenditures and $37 million on dividends. Net interest expense was $56 million, compared with $38 million a year earlier. In August it issued $600 million of 5.50% notes due 2031 and $500 million of 6.00% notes due 2036, and it repaid $700 million of 1.650% notes at maturity.
What management is watching
- Medicaid and insurance changes: Under the One Big Beautiful Bill Act, the company estimates that, starting with 2028 state fiscal years, its annual net benefit from Medicaid supplemental payment programs will be reduced by approximately $500 million by 2032. That compares with a 2026 full year net benefit of approximately $1.584 billion. Medicaid work requirements take effect January 1, 2027, and expired insurance exchange subsidies have already raised uncompensated care.
- Spending: Full year capital expenditures are expected at approximately $900 million to $1.0 billion. The company also pointed to cost pressures, including physician expenses and new California staffing standards effective June 1, 2026.
- Funding timing: Temporary federal funding runs through December 11, 2026, and the company said a government shutdown could hurt operating cash flows.
- Measures: Management points investors to Same Facility results, a non-GAAP measure (not based on standard accounting rules) that excludes provider tax assessments. These are state fees that offset between revenue and expense.
New or changed risks
- Talkspace integration: The company paid approximately $820 million, net of cash acquired, using borrowings. Risks include slow synergies, loss of key employees or providers, and distraction of management.
- Washington, D.C. hospitals: A new arrangement with The George Washington University and its faculty medical group is under review by the D.C. Attorney General. The review could approve, reject or condition the deal, and could lead to it being unwound.
- Physician group losses: The company took on management and financial responsibility for Capital Medical Group effective August 1, 2026. It warns that losses could exceed expectations, and that university support ends after five years.
Follow UHS in Kortex
The Kortex app shows UHS's price, options chain and IV rank, and answers your questions from live market data and SEC filings.
Free to download.
Learn the strategies
More stock briefs
For education only, not financial advice. Options involve risk and are not suitable for every investor.